Meditron SA
Meditron reported total assets of 488,085 € at the end of the 2025 financial year (annual accounts filed with the NBB on 26 Feb 2026).
The score of Meditron shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +35 % Total assets -5 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Meditron's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 22,383 € | ||||
| Equity | 433,685 € | ||||
| Cash | 42,050 € | ||||
| EBITDA | 32,850 € | ||||
| Total assets | 488,085 € |
Filed annual accounts
- Year ended 30 Sep 2025filed on 26 Feb 2026
- Year ended 30 Sep 2024filed on 27 Feb 2025
- Year ended 30 Sep 2023filed on 29 Feb 2024
- Year ended 30 Sep 2022filed on 07 Mar 2023
- Year ended 30 Sep 2021filed on 24 Feb 2022
Meditron's financial analysis
- Solvency88.9%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Meditron
Meditron's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0461.538.767
- VAT number
- BE0461538767
- Peppol
- Registered · 0208:0461538767 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 01 Oct 1997
- Registered office
- 9170 Sint-Gillis-Waas
- Latest accounts
- 2025 · filed on 26 Feb 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Meditron (SA) has been based in Sint-Gillis-Waas since 1997, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 22,383 € and equity of 433,685 €; its revenue is not published. Its solvency stands at 88.9%, above the median of its sector (46.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Meditron
Companies in the same business, of comparable size and area, outside its group.
- Arna Logistics Wholesale of pharmaceutical and medical goods Ath · balance sheet 502,130 €
- Krekel Mobility Wholesale of pharmaceutical and medical goods Wemmel · balance sheet 321,255 €
- Dentaurum Benelux Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 821,866 €
- Medilaser Wholesale of pharmaceutical and medical goods Geel · balance sheet €1.02m
- Medical Care Systems Wholesale of pharmaceutical and medical goods Gingelom · balance sheet 501,640 €
- Urservices Wholesale of pharmaceutical and medical goods Zottegem · balance sheet 570,973 €
- Mobimed Wholesale of pharmaceutical and medical goods Roeselare · balance sheet 600,671 €
- Medsupplies Wholesale of pharmaceutical and medical goods Oudenaarde · balance sheet 743,904 €
Frequently asked questions about Meditron
What is the revenue of Meditron?
Meditron files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Meditron?
In Belgium, the VAT number is the company number prefixed with BE: BE0461538767 for Meditron, if the company is VAT-registered. Its company number (CBE) is 0461.538.767.
Where is the registered office of Meditron?
According to the CBE register, the registered office of Meditron is in 9170 Sint-Gillis-Waas.
What is the equity of Meditron?
At the close of the 2025 financial year, the equity of Meditron amounts to 433,685 €, a solvency of 88.9% of total assets.
Who manages Meditron?
The register lists 4 active mandates at Meditron. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Meditron
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →